RS

Rajiv Sharma

Director Director DIN 07920328
DIN 07920328 First appointment Aug 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2017
Shareholding value •••• Premium profile

About Rajiv Sharma

Data last updated:

Rajiv Sharma was a Director at Preet Remedies Limited (2017–2018) and Director at Oasis Pharma And Phytomolecules Private Limited (2017–2018). The companies operate in Pharma.

DIN 07920328
Primary Designation Director
Industry Pharma
First Appointment 26 Aug 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Preet Remedies Limited U24230CH2005PLC027954
Director26 Aug 20172005₹62.83 Cr (FY 2025)Active
Director26 Aug 20172007₹10.36 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Preet Remedies Limited
Oasis Pharma And Phytomolecules Private Limited
Premium access

Shareholding and investment profile for Rajiv Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Sharma

Rajiv Sharma was first appointed on 26 Aug 2017 as Director at Preet Remedies Limited.

Rajiv Sharma held 2 earlier board appointments: Preet Remedies Limited (Director, 26 Aug 2017 to 28 Mar 2018); Oasis Pharma And Phytomolecules Private Limited (Director, 26 Aug 2017 to 28 Mar 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available